These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1449812)

  • 1. Twelve year experience with the modified Blalock-Taussig shunt in neonates.
    Fermanis GG; Ekangaki AK; Salmon AP; Keeton BR; Shore DF; Lamb RK; Monro JL
    Eur J Cardiothorac Surg; 1992; 6(11):586-9. PubMed ID: 1449812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic-pulmonary shunts in infants and children. Early and late results.
    Lamberti JJ; Carlisle J; Waldman JD; Lodge FA; Kirkpatrick SE; George L; Mathewson JW; Turner SW; Pappelbaum SJ
    J Thorac Cardiovasc Surg; 1984 Jul; 88(1):76-81. PubMed ID: 6204171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Side-to-side aorto-GoreTex central shunt warrants central shunt patency and pulmonary arteries growth.
    Barozzi L; Brizard CP; Galati JC; Konstantinov IE; Bohuta L; d'Udekem Y
    Ann Thorac Surg; 2011 Oct; 92(4):1476-82. PubMed ID: 21958799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A five-year clinical experience with 112 Blalock-Taussig shunts.
    Gold JP; Violaris K; Engle MA; Klein AA; Ehlers KH; Lang SJ; Levin AR; Moran F; O'Loughlin JE; Snyder MS
    J Card Surg; 1993 Jan; 8(1):9-17. PubMed ID: 8422496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with the modified Blalock-Taussig operation using polytetrafluoroethylene (Impra) grafts.
    Kay PH; Capuani A; Franks R; Lincoln C
    Br Heart J; 1983 Apr; 49(4):359-63. PubMed ID: 6830670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Growth of the pulmonary arteries and morphological assessment after Blalock-Taussig shunts].
    Honda J
    Nihon Kyobu Geka Gakkai Zasshi; 1993 Apr; 41(4):569-77. PubMed ID: 8515154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The modified blalock-taussig shunt using microporous expanded polytetrafluoroethylene (PTFE).
    Lawless CE; Smith EE; Hallidie-Smith K; Sapsford RN
    J Cardiovasc Surg (Torino); 1982; 23(4):287-92. PubMed ID: 7107686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of Blalock-Taussig, Waterston, and polytetrafluoroethylene shunts in children less than two weeks of age.
    Woolf PK; Stephenson LW; Meijboom E; Bavinck JH; Gardner TJ; Donahoo JS; Edie RN; Edmunds LH
    Ann Thorac Surg; 1984 Jul; 38(1):26-30. PubMed ID: 6203495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classic Blalock-Taussig shunt in neonates.
    Yoshimura N; Yamaguchi M; Ohashi H; Oshima Y; Toyoda Y; Ogawa K
    J Cardiovasc Surg (Torino); 1999 Feb; 40(1):107-10. PubMed ID: 10221395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The modified Blalock-Taussig shunt: clinical impact and morbidity in Fallot's tetralogy in the current era.
    Gladman G; McCrindle BW; Williams WG; Freedom RM; Benson LN
    J Thorac Cardiovasc Surg; 1997 Jul; 114(1):25-30. PubMed ID: 9240290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic-pulmonary polytetrafluoroethylene shunts in palliative operations for congenital heart disease. Revival of the central shunt.
    Amato JJ; Marbey ML; Bush C; Galdieri RJ; Cotroneo JV; Bushong J
    J Thorac Cardiovasc Surg; 1988 Jan; 95(1):62-9. PubMed ID: 2447447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aorta-pulmonary artery shunts with expanded polytetrafluoroethylene (PTFE) tube.
    Miyamoto K; Zavanella C; Lewin AN; Subramanian S
    Ann Thorac Surg; 1979 May; 27(5):413-7. PubMed ID: 454015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palliation in cyanotic congenital heart disease. Fifteen years' experience of various shunt procedures.
    Wright J; Albrecht H; Beveridge J
    Med J Aust; 1986 Feb; 144(4):178-9, 182. PubMed ID: 2418340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified Blalock-Taussig shunt in newborn infants.
    Ilbawi MN; Grieco J; DeLeon SY; Idriss FS; Muster AJ; Berry TE; Klich J
    J Thorac Cardiovasc Surg; 1984 Nov; 88(5 Pt 1):770-5. PubMed ID: 6492843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Criterions for selection of patients for, and results of, a new technique for construction of the modified Blalock-Taussig shunt.
    Chowdhury UK; Venugopal P; Kothari SS; Saxena A; Talwar S; Subramaniam G; Singh R; Pradeep KK; Sathia S; Kumar AS
    Cardiol Young; 2006 Oct; 16(5):463-73. PubMed ID: 16984698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with polytetrafluoroethylene grafts in children with cyanotic congenital heart disease.
    Opie JC; Traverse L; Hayden RI; Ho CY; Culham JA; Ashmore PG
    Ann Thorac Surg; 1986 Feb; 41(2):164-8. PubMed ID: 3947169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative angiographic assessment of modified Blalock-Taussig shunts using expanded polytetrafluoroethylene (Gore-Tex).
    McKay R; de Leval MR; Rees P; Taylor JF; Macartney FJ; Stark J
    Ann Thorac Surg; 1980 Aug; 30(2):137-45. PubMed ID: 7416836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classic shunting operations for congenital cyanotic heart defects.
    Arciniegas E; Farooki ZQ; Hakimi M; Perry BL; Green EW
    J Thorac Cardiovasc Surg; 1982 Jul; 84(1):88-96. PubMed ID: 7087545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polytetrafluoroethylene shunts in congenital heart disease.
    Nanton MA; Roy DL; Murphy DM; Finley JP; Lau H; Gillis DA; Murphy DA
    Can J Surg; 1982 Mar; 25(2):134-8. PubMed ID: 7066772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Systemic pulmonary shunts in the neonatal period. Short and medium-term results].
    Chantepie A; Cheliakine-Chamboux C; Aupart M; Bry P; Vaillant MC; Marchand M
    Arch Mal Coeur Vaiss; 1995 May; 88(5):693-8. PubMed ID: 7646279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.